Recipharm has opened a newly built GMP suite for clinical trial material (CTM) manufacture at its facility in Research Triangle Park, NC. The suite, which represents a $750,000 investment, is intended to produce CTM for clinical studies up to Phase II for non-sterile dosage forms, including metered dose inhalers and semi-solid topical products. With the introduction of the GMP suite, the contract development and manufacturing organization (CDMO) can now provide complete early development s...